Absci Corp

NASDAQ:ABSI 4:00:00 PM EDT

4.97

-0.32 (-6.05%)

7:35:05 PM EDT: $5.00 +0.03 (+0.60%)

Market Cap (Intraday)	560.54M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$2.1 Million
Adjusted EPS	-$0.21

See more estimates

10-Day MA	$5.49
50-Day MA	$5.13
200-Day MA	$2.90

See more pivots

Absci Corp Stock, NASDAQ:ABSI

18105 SE Mill Plain Boulevard, Suite 350, Vancouver, Washington 98683

United States of America

Phone: +1.360.949.1041

Number of Employees: 156

http://www.absci.com

Description

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.